Pilot secondary analysis of a trial of vaginal estradiol or moisturiser vs placebo: in 14 postmenopausal participants with genitourinary syndrome of menopause, responders had longer CD31+ vessel length at 12 weeks than nonresponders (P=0.034); other measures were similar.
Secondary analysisn = 14
Dotson et al. A pilot study of vaginal nerve fiber and blood vessel density in postmenopausal women with genitourinary syndrome of menopause